Suppr超能文献

前沿:白细胞介素-6的重要性以及天然免疫受体与适应性免疫受体在B淋巴细胞细胞疫苗接种中的协同作用

Cutting Edge: Importance of IL-6 and cooperation between innate and adaptive immune receptors in cellular vaccination with B lymphocytes.

作者信息

Vanden Bush Tony J, Buchta Claire M, Claudio Jennifer, Bishop Gail A

机构信息

Department of Microbiology, University of Iowa, Iowa City, IA 52242, USA.

出版信息

J Immunol. 2009 Oct 15;183(8):4833-7. doi: 10.4049/jimmunol.0900968.

Abstract

B lymphocytes are a potential alternative to dendritic cell immunotherapy, with the advantages of relative abundance in peripheral blood and the ability to function as APCs. Although B cells express multiple receptors that induce costimulatory molecules, B cell vaccine studies have focused primarily on CD40 stimulation. To optimize the potential efficacy of B cell vaccines (Bvac), we compared the capacity of differentially stimulated B cells to induce Ag-specific CD8(+) T cell responses in vivo. CD40- or TLR7-stimulated B cell APCs induced similar CD8(+) T cell responses, but costimulation through the BCR and TLR7 produced a more effective Bvac as measured by T cell stimulation and the protection of mice from an infectious pathogen. This increased effectiveness depended upon enhanced production of IL-6 by BCR plus TLR7-stimulated B cells. These findings reveal alternative stimulation strategies for the production of effective Bvac and identify a key role for IL-6 in B cell Ag presentation and cellular vaccines.

摘要

B淋巴细胞是树突状细胞免疫疗法的一种潜在替代方案,具有外周血中相对丰富以及能够作为抗原呈递细胞发挥功能的优势。尽管B细胞表达多种诱导共刺激分子的受体,但B细胞疫苗研究主要集中在CD40刺激上。为了优化B细胞疫苗(Bvac)的潜在疗效,我们比较了不同刺激的B细胞在体内诱导抗原特异性CD8(+) T细胞反应的能力。CD40或TLR7刺激的B细胞抗原呈递细胞诱导了相似的CD8(+) T细胞反应,但通过BCR和TLR7的共刺激产生了一种更有效的Bvac(通过T细胞刺激以及保护小鼠免受感染性病原体的侵害来衡量)。这种增强的有效性取决于BCR加TLR7刺激的B细胞增强的IL-6产生。这些发现揭示了产生有效Bvac的替代刺激策略,并确定了IL-6在B细胞抗原呈递和细胞疫苗中的关键作用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验